Prevalence of chronic obstructive pulmonary disease and associated symptoms in the province of Pamplona, Norte de Santander in 2010
Prevalencia de enfermedad pulmonar obstructiva crónica y síntomas asociados en la provincia de pamplona, norte de santander en el año 2010
Article Sidebar
PDF (Español (España))
FLIP
COPYRIGHT NOTICE
The authors who publish in the Movimiento Científico Journal agree with the following terms:
1. The authors retain the copyright and guarantee the journal the right to be the first publication of the work, as well as licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International that allows others to share the work with an acknowledgment of authorship , the mixture or remix must be published under the same initial publication license, does not allow commercial exploitation of it.
2. The concepts and opinions expressed in the articles are the sole responsibility of the authors and do not commit the Ibero-American University Corporation. The contents of this magazine are distributed under license: Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International.
3. The Movimiento Científico Journal is open access, so that both the editorial process and the published content are available to all users free of charge: the Magazine does not charge for reading or publishing.
Responsibilities. The concepts, opinions and ideas expressed in the published articles are the responsibility of the authors.For purposes of compliance with this point the authors must fill out the Letter of originality, which will be sent along with the article to the magazine's mail.
Main Article Content
Chronic obstructive pulmonary disease (COPD), characterized by airflow limitation, has become a major cause of morbidity and mortality in developed countries. In Latin America, Colombia and Northern Santander, epidemiological data are scarce. The purpose of the basic research project for this article was to carry out a study aimed at measuring the prevalence of this disease and associated symptoms such as chronic cough and dyspnea in patients over 45 years of age, in the municipalities that make up the province of Pamplona, Norte de Santander, through the review of the individual health service provision records (RIPS), of the health providing entities that provide the general medicine service in said municipalities, during
the year 2010 in order to select, condense and analyze the information.
Downloads
Article Details
Caballero, A., Torres-Duque CA, y Otros. (2007). Prevalence of Chronic Obstructive Pulmonary Disease in five Colombian cities situated at low, medium and high altitude (PREPOCOL Study).
Chest Papers In Press, prepublished online; DOI:10.1378/ chest.07-1361.
Calverley, PMA. (1996). Neuropsychological deficits in chronic obstructive pulmonary disease. Monal di Arch Chest Dis, 51(1): 5-6.
Celli, B., MacNee, W. (2004). ATS/ERS Task Force. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir, 23: 932-46.
Chapman KR., Mannino DM, Soriano JB., Vermeire PA., Buist AS., Thun MJ., et al.(2006). Epidemiology and costs of chronic obstructive pulmonary disease. Eur Respir J, 27(1):188-207.
Chols, AM., Soeters, PB., Dingemans, AM., Mostert R., Frantzen, PJ., Wouters EF. (1993). Prevalence and characteristics of nutritional depletion in patients with stable COPD eligible for pulmonary rehabilitation, Am Rev Respir Dis, 47(5):1151-6.
Estrategia global para el diagnóstico, tratamiento y prevención de la enfermedad pulmonar obstructiva crónica. (2006). Medical Communications Resources, Inc.
Fukuchi, Y., Nishimura, M., Ichinose, M., Adachi, M., Nagai, A., Kuriyama, T., et al. (2004). COPD in Japan: the Nippon COPD Epidemiology study. Respirology, 9(4):458-65.
Georgopoulas, D., Anthonisen, NR. (1991). Symptoms and signs of COPD. In: Cherniack NS, ed. Chronic obstructive pulmonary disease. WB Saunders Co, 357-63.
Halbert, RJ., Natoli, JL., Gano, A., Badamgarav, E., Buist, AS., Mannino, DM. (2006). Global burden of COPD: systematic review andmeta-analysis. Eur Respir J.
Hurd, S. (2000). The impact of COPD on lung health worldwide: epidemiology and incidence. Chest, 117(2 Suppl): 1S-4S.
Silverman EK., Palmer LJ., Mosley JD, Barth M., Senter JM., Brown A., et al. (2002). Genome widelink age analysis of quantitative spirometric phenotypes in severe early-onset chronic obstructive pulmonary disease. Am J Hum Genet; 70(5):1229-39.
Silverman, EK., Weiss, ST., Drazen, JM., Chapman, HA., Carey, V., Campbell EJ, et al. (2000). Genderrelated differences in severe, early-onset chronic obstructive pulmonary disease. Am J Respir Crit Care Med, 162(6):2152-8.
Soriano JB., Visick GT., Muellerova H., Payvandi N., Hansell AL. (2005). Patterns of comorbidities in newly diagnosed COPD and asthma in primary care. Chest;128(4):2099-107
Stoller JK., Aboussouan LS. (2005). Alpha1-antitrypsin deficiency. Lancet; 365(9478):2225-36.
Xu, X., Weiss, ST, Rijcken, B., Schouten, JP. (1994). Smoking, changes in smoking habits, and rate of decline in FEV1: new insight into gender differences. Eur Respir J, 7(6):1056-61.
